Results 151 to 160 of about 197,499 (175)

Long-acting growth hormone in the management of GHD in France

Archives de Pédiatrie
Approximately 10,000 children in France with growth hormone deficiency (GHD) are being administered daily recombinant human growth hormone (rhGH). Although this treatment has long proved efficient for restoring children's growth and metabolism, daily injections of rhGH have a few limitations, such as difficulties in terms of adherence to treatment ...
Agnès Linglart, Régis Coutant, Michel Polak, Marc Nicolino   +3 more
openaire   +2 more sources

Update on the use of long-acting growth hormone in children

Current Opinion in Pediatrics
Purpose of review After extensive research and many years of waiting, long-acting growth hormone (LAGH) formulations have finally become a reality in clinical practice and emerge as a potential solution to address the challenges of daily injections of recombinant human GH (rhGH).
Margaret Cristina da Silva, Boguszewski, Cesar Luiz, Boguszewski   +1 more
openaire   +2 more sources

Comparative analysis of long-acting growth hormone and short-acting growth hormone in the treatment of growth hormone deficiency

Minerva Pediatrics, 2022
Jia, Sun, Mian, Wang, Zhongyan, Huang, Wenjuan, Zhong, Yahui, Yang   +4 more
openaire   +2 more sources

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Clinical translation of long-acting drug delivery formulations

Nature Reviews Materials, 2022
Wei Li, Dennis Lee, Thomas R Tice
exaly  

Somatrogon. Long-acting human growth hormone, Treatment of human growth hormone deficiency

Drugs of the Future, 2021
openaire   +1 more source

Long-Acting Therapies Will Expand Growth Hormone Deficiency Market.

P & T : a peer-reviewed journal for formulary management, 2015
Future therapies for growth hormone deficiency are expected to include long-acting formulations that may encourage increased use of and adherence to these products.
openaire   +1 more source

Long-Acting Growth Hormone Preparations in the Treatment of Children.

Pediatric endocrinology reviews : PER, 2019
Human growth hormone (hGH), which had been in use since 1958, was supplanted by recombinant human growth hormone (rhGH) in 1985 for those with growth hormone deficiency (GHD). Adherence to daily subcutaneous growth hormone is challenging for patients. Thus, several companies have pursued the creation of long acting rhGH.
Rayhan A, Lal, Andrew R, Hoffman
openaire   +1 more source

Efficacy and safety of long-acting growth hormone in adult growth hormone deficiency: A systematic review and meta-analysis

Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2022
Deep Dutta, Kunal Mahajan, MEHA SHARMA
exaly  

Safety of long-term use of daily and long-acting growth hormone in growth hormone-deficient adults on cancer risk

Best Practice and Research in Clinical Endocrinology and Metabolism, 2023
César L Boguszewski
exaly